Naturalendo Tech

내츄럴엔도텍 · 168330

Industrials Commercial Services · KOSDAQ

Small-cap

Market cap US$54.1M (₩74.6B)

Overview

Naturalendo Tech makes natural-ingredient health supplements and skincare products aimed at anti-aging and general wellness, and also develops microneedle patches, tiny needle-based skin patches that deliver active ingredients through the skin without pain.

Its products reach consumers through the health-food and cosmeceutical (functional cosmetics) markets. Listed on KOSDAQ, Korea's tech and small-cap board, the company operates across two main lines: a healthcare range built around proprietary natural extracts, and a beauty range that includes the microneedle patch technology developed by its subsidiary, Endoderma.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$16.1M

▼ −0.2% YoY

Operating profit · FY2025

−US$2.4M

Loss narrowed

Net income · FY2025

−US$2.6M

Loss narrowed

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$13.6M(₩18.8B)	US$16.1M(₩22.3B)	US$16.1M(₩22.2B)
Operating profit	−US$3M(−₩4.1B)	−US$2.7M(−₩3.8B)	−US$2.4M(−₩3.3B)
Net income	−US$4.1M(−₩5.6B)	−US$3M(−₩4.1B)	−US$2.6M(−₩3.6B)

Revenue

FY2023US$13.6M
FY2024US$16.1M
FY2025US$16.1M

Operating profit

FY2023−US$3M
FY2024−US$2.7M
FY2025−US$2.4M

Net income

FY2023−US$4.1M
FY2024−US$3M
FY2025−US$2.6M

Key ratios (FY2025)

ROE

-15.6%

Debt/Eq

54.1%

Op. margin

-14.8%

Net margin

-16.3%

Rev. YoY

▼ −0.2%

Why it matters

The microneedle patch technology is researched and developed through a subsidiary named Endoderma, making that unit a distinct operating entity within the company.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?